According to Clovis Oncology's latest financial reports the company has HK$0.45 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2021-12-31 | HK$1.11 B | -39.95% |
2020-12-31 | HK$1.86 B | -19.4% |
2019-12-31 | HK$2.31 B | -43.28% |
2018-12-31 | HK$4.07 B | -7.52% |
2017-12-31 | HK$4.40 B | 113.38% |
2016-12-31 | HK$2.06 B | -49.62% |
2015-12-31 | HK$4.09 B | 9.43% |
2014-12-31 | HK$3.74 B | 49.37% |
2013-12-31 | HK$2.50 B | 124.4% |
2012-12-31 | HK$1.11 B | 2.54% |
2011-12-31 | HK$1.08 B | 527.71% |
2010-12-31 | HK$0.17 B |